TCTR20180531004Active, not recruitingPhase 4
eutralizing Immunogenicity Antibody After 2 Intradermal Doses Pre-Exposure Prophylaxis of Purified Vero Cell Rabies Vaccine (PVRV) to 12-24 month-old Children, concomitantly with Chimeric Live-Attenuated JE Vaccine (IMOJEV)
Queen Saovabha Memorial Institute, The Thai Red Cross Society0 sites49 target enrollmentStarted: May 31, 2018Last updated:
Conditions
Trial Snapshot
- Phase
- Phase 4
- Status
- Active, not recruiting
- Sponsor
- Enrollment
- 49
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
- Ages
- 1 Years to 5 Years (—)
- Sex
- All
Inclusion Criteria
- •1) Children aged 12-24 months 2) In a good general health after physical exam at the time of inclusion 3) Informed consent form has been signed and dated by the parent(s)/legal guardian(s) 4) Be able to complete the vaccine course and every blood sample collection
Exclusion Criteria
- •1) History of receiving rabies vaccination or Rabies Nab titers ≥ 0.5 IU/ml 2) History of receiving JE vaccination 3) Contraindications to Live attenuated vaccine i.e. immunodeficiency, cancer with treatment of immunosuppressive agents 4) Parents reject to participate in study 5) History of receiving any vaccine in the 8 weeks preceding the study
Investigators
Similar Trials
Active, not recruiting
Phase 1
Immunity after Tick Borne Encephalitis vaccination in stem cell transplanted patientsPatients have undergone allogeneic or autologous stem cell transplantation for hematological malignancies.EUCTR2014-003573-42-SEVästra Götalandsregionen90
Active, not recruiting
Phase 1
Induction of Cross-neutralizing Antibodies After Primary Vaccination With Two Different Tick- borne Encephalitis Virus VaccinesThe study is exploring the cross neutralizing potential of human sera after primary immunization with FSME-IMMUN 0.5 ml or Encepur 0.5 ml against different strains within the same TBEV subtype, other TBEV subtypes, closely related viruses of the TBEV serogroup, and also more distantly related flaviviruses, based on the use of a hybrid virus assay platformEUCTR2016-003124-23-ATMedical University of Vienna, ISPTM60
Recruiting
Not Applicable
MOODSTRATIFICATION IMMUNOSTRATAPremature immune ageing to predict the effect of physical training intervention, in mood disordersF32F33F31Depressive episodeRecurrent depressive disorderBipolar affective disorderDRKS00022887niversitätsklinikum Münster500
Recruiting
Not Applicable
CIMAvax-EGF in different maintenance schemeson small cell lung cancerCarcinoma, Non-Small-Cell LungCarcinoma, BronchogenicBronchial NeoplasmsLung NeoplasmsRespiratory Tract NeoplasmsThoracic NeoplasmsLung DiseasesRespiratory Tract DiseasesNSCLCRPCEC00000368Center of Molecular Immunology (CIM)42
Recruiting
Not Applicable
Evaluation of antibody production after vaccination with COVID-19 in volunteer donorsJPRN-jRCT1071210129Kawasaki Tatsuhiko30